These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9010026)

  • 1. Plateau-phase cultures: an experimental model for identifying drugs which are bioactivated within the microenvironment of solid tumours.
    Phillips RM; Clayton MR
    Br J Cancer; 1997; 75(2):196-201. PubMed ID: 9010026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of low pH and hypoxia on the cytotoxic effects of SR4233 and mitomycin C in vitro.
    Skarsgard LD; Vinczan A; Skwarchuk MW; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):363-7. PubMed ID: 8195034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures.
    Rockwell S; Hughes CS
    Cell Prolif; 1994 Mar; 27(3):153-63. PubMed ID: 10465006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.
    Skarsgard LD; Skwarchuk MW; Vinczan A; Chaplin DJ
    Br J Cancer; 1993 Oct; 68(4):681-3. PubMed ID: 8398693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.
    Finlay GJ; Wilson WR; Baguley BC
    Br J Cancer; 1987 Dec; 56(6):755-62. PubMed ID: 3435703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model.
    Kyle AH; Minchinton AI
    Cancer Chemother Pharmacol; 1999; 43(3):213-20. PubMed ID: 9923551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
    Siim BG; van Zijl PL; Brown JM
    Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs.
    Phillips RM
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):441-57. PubMed ID: 26811177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours.
    Phillips RM; Loadman PM; Cronin BP
    Br J Cancer; 1998 Jun; 77(12):2112-9. PubMed ID: 9649122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro.
    Rockwell S
    Int J Cancer; 1986 Aug; 38(2):229-35. PubMed ID: 3089943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL; Hargreaves RH; Butler J; Ross D
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
    Gibson NW; Hartley JA; Butler J; Siegel D; Ross D
    Mol Pharmacol; 1992 Sep; 42(3):531-6. PubMed ID: 1406604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diarylsulfonylureas and radiotherapy. I. In vitro studies with N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea (Sulofenur).
    Rockwell S; Grindey GB
    Cancer Commun; 1991 Apr; 3(4):103-8. PubMed ID: 2025495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.
    Drewinko B; Patchen M; Yang LY; Barlogie B
    Cancer Res; 1981 Jun; 41(6):2328-33. PubMed ID: 7237431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity.
    Phillips RM; Hulbert PB; Bibby MC; Sleigh NR; Double JA
    Br J Cancer; 1992 Mar; 65(3):359-64. PubMed ID: 1558788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells.
    Hixson LJ; Alberts DS; Krutzsch M; Einsphar J; Brendel K; Gross PH; Paranka NS; Baier M; Emerson S; Pamukcu R
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):433-8. PubMed ID: 7920212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.
    Lartigau E; Guichard M
    Br J Cancer; 1996 Jun; 73(12):1480-5. PubMed ID: 8664116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.